Risk factors for fellow eye treatment in protocol T
Sign Up to like & getrecommendations! Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-021-05108-0
Abstract: To identify risk factors for fellow eye treatment of diabetic retinopathy with Vascular Endothelial Growth Factor (VEGF) injections during the Diabetic Retinopathy Clinical Research Network (DRCR.Net) Protocol T trial In this post-hoc analysis of randomized… read more here.
Keywords: treatment; eye treatment; risk factors; fellow eye ... See more keywords
27 Topical eye treatment with p-blocker abolishes sweat secretion triggered by intradermal isoprenaline plus aminophylline: a clinical observation
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cystic Fibrosis"
DOI: 10.1016/s1569-1993(17)30392-2
Abstract: Objectives: Two new versions of the sweat test have recently been developed with claimed advantages of being sensitive enough to quantify residual CFTR function and to measure efficacy of basic therapies. Methods: Rates of water… read more here.
Keywords: secretion; treatment blocker; plus aminophylline; eye treatment ... See more keywords